Exchange: NASDAQ·Updated 03:59 PM EST

AACP News

News
all
press releases
AbbVie will acquire Apogee Therapeutics for $10.9 billion, with analyst citing long-term immunology growth despite near-term dilution.read more...
Benzinga

Advertisement|Remove ads.